Return
Advancing Cancer Interception
DOI:10.1158/2159-8290.CD-24-0015.png)
Abstract
En 中文
Rapid advances in technology and therapeutics, along with better methods to discern who is at risk for cancer by genetic testing and other means, has enabled the development of cancer interception. Targeted therapies and immuno-interception may eliminate premalignant lesions and require clinical trial and treatment paradigms altogether distinct from current approaches.
Keywords:
PREVENTION

